Q3 2022 Holdings
Filed 2022-11-14 | 73 holdings | $185.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $44.0M | 3,442,863 | 23.7% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $31.0M | 3,170,872 | 16.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $21.6M | 1,450,000 | 11.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $19.1M | 1,000,000 | 10.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $17.2M | 610,000 | 9.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $14.6M | 1,469,179 | 7.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.3M | 296,000 | 7.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $8.8M | 1,547,181 | 4.7% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $6.8M | 712,079 | 3.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 50,000 | 2.8% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $839.0K | 392,167 | 0.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $750.0K | 1,154,424 | 0.4% |
| Prometheus Biosciences Inc | COM | 74349U108 | $116.8K | 1,979,158 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $100.9K | 1,478,000 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $83.6K | 5,000,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $81.9K | 10,505,554 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $57.2K | 3,049,173 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $47.1K | 6,065,001 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $40.2K | 575,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $39.3K | 1,995,066 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $38.6K | 2,330,691 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $38.3K | 3,198,382 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $33.8K | 1,971,422 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $33.7K | 150,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $32.9K | 2,012,115 | 0.0% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $32.7K | 2,286,181 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $30.0K | 3,051,989 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $28.0K | 184,894 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $27.3K | 780,646 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $26.9K | 1,310,000 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $24.5K | 2,993,717 | 0.0% |
| Greenlight Biosciencs Hlds P | COMMON STOCK | 39536G105 | $23.8K | 10,261,560 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $22.7K | 322,240 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $22.1K | 200,000 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $20.6K | 600,000 | 0.0% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $19.9K | 1,400,000 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $16.8K | 2,181,115 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $16.4K | 782,788 | 0.0% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $15.2K | 2,536,617 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $14.9K | 4,116,949 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $14.0K | 1,087,807 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.9K | 868,550 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $11.4K | 2,326,660 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $10.8K | 1,200,000 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $9.7K | 30,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $9.3K | 1,207,500 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $9.0K | 500,000 | 0.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $7.9K | 1,972,728 | 0.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $7.9K | 2,118,283 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $6.9K | 593,043 | 0.0% |